Streptococcus pneumoniae encounters a number of environmental niches in the body, including the nasopharynx, lungs, blood, middle ear, and brain. Recent studies have identified 13 putative two-component signal-transduction systems in S. pneumoniae, which are likely to be important for gene regulation in response to external stimuli. Here, we present conclusive evidence for the regulation of choline binding protein A (CbpA), a major pneumococcal virulence factor and protective antigen, by one of these two-component signal-transduction systems. We have demonstrated divergent expression of cbpA in unmarked hk06 and rr06 deletion mutants relative to wild-type S. pneumoniae D39 by using Western immunoblotting and real-time RT-PCR. Electrophoretic mobility-shift and solid-phase binding assays have demonstrated the binding of RR06 to the promoter region of cbpA, suggesting that RR06͞HK06 directly regulates cbpA transcription. We have also shown that this system is important for the ability of the pneumococcus to adhere to epithelial cells in vitro and to survive and proliferate in an in vivo mouse model. Thus, the RR06͞HK06 system has a significant role in pathogenesis, both in colonization and invasive disease.
T
he major human pathogen Streptococcus pneumoniae is responsible for diseases, including pneumonia, sepsis, meningitis, and otitis media. During the course of an infection, the pneumococcus encounters a number of different environmental niches, including the nasopharynx, lungs, blood, and potentially the brain. Thus, the regulation of virulence factors in response to external stimuli may be a principal determinant of the success or failure of the infection. Recently, several virulence-associated genes of S. pneumoniae have been shown to be differentially expressed in varying in vitro and in vivo conditions, but the underlying mechanism is unknown (1, 2) . Two-component signal-transduction systems (TCSTSs) control the expression of virulence factors in a wide range of bacterial species in response to external stimuli (reviewed in ref.
3). The typical TCSTS consists of a His kinase (HK) and a response regulator (RR). The HK, usually present in the cell membrane, responds to external stimuli by autophosphorylating a conserved His residue, with subsequent transfer of this phosphate group to the RR. The resultant conformational change enables the RR to bind to the promoter region of target gene(s) and act as a transcription factor.
The S. pneumoniae genome sequence contains 13 putative TCSTSs, along with one orphan RR (4, 5) . The best characterized of these is ComDE, which activates the genetic competence system in response to a competence-stimulating peptide (6, 7) . Another system, CiaRH, also affects competence and has been shown to control a novel virulence factor, HtrA (8, 9) . More recently, HK͞RR04 has been linked to the control of the Mn transporter PsaA, although this regulation was apparently strainspecific (10) . In this study, we used unmarked deletion mutants to examine the role of the RR06͞HK06 TCSTS (4) (also referred to as 478; ref. 5 ) in pathogenesis and identify a crucial target gene, cbpA. These findings provide conclusive evidence for regulation of a major pneumococcal virulence factor and protective antigen by a TCSTS, and they demonstrate binding of RR06 to the promoter region of cbpA.
Materials and Methods
Bacterial Strains, Plasmids, Growth Conditions, and Transformation.
Bacterial strains and plasmids are given in Table 1 , which is published as supporting information on the PNAS web site. S. pneumoniae were grown in Todd Hewitt broth with 1% yeast extract (THY), serum broth (SB), or on blood agar, as described (2) . Escherichia coli strains were grown in LB broth or LB agar (11) . S. pneumoniae D39 and TIGR4 were transformed as described, with competence-stimulating peptide-2 used to transform TIGR4 (12) (13) (14) . Transformation of E. coli K-12 with plasmid DNA was carried out with CaCl 2 -treated cells (15) .
Oligonucleotide Primers, DNA Isolation, and Manipulation. The primers that were used are given in Table 2 , which is published as supporting information on the PNAS web site. S. pneumoniae chromosomal DNA was isolated, purified, and analyzed as described (16) . DNA amplification was performed by highfidelity PCR using the Expand Long Template PCR system (Roche Diagnostics). Overlap-extension PCR products were generated from the initial products as described (17, 18) . Amplification products were purified by using the UltraClean PCR CleanUp DNA purification kit (Qiagen, Valencia, CA) and sequenced by using the Big Dye system (Applied Biosystems) on a model 3700 automated sequencer.
Construction of S. pneumoniae with Deletions in rr06 and hk06.
Initially, an insertion-duplication mutant in rr06 was constructed essentially as described (19) by using oligonucleotides Sp7c and Sp7d. Because insertion duplication can result in the production of truncated gene products, as well as possible polar effects on downstream genes, unmarked deletion mutations in the hk06 and rr06 genes were constructed by using overlap-extension PCR mutagenesis (17, 18) . For hk06, separate 5Ј-and 3Ј-flanking fragments were generated by using PCR with D39 DNA template and primer pairs AS5͞AS14 and AS6͞AS13. The two PCR products were then combined and subjected to a second round of amplification by using the primer pair AS5͞AS6. This PCR generated a 5,720-bp linear DNA fragment comprising the hk06 gene with flanking sequences but with nucleotides 73-1,308 of the hk06 ORF deleted. Nucleotides 23-639 of the rr06 gene were similarly deleted by using primers AS6͞AS10 and AS5͞AS11 in This paper was submitted directly (Track II) to the PNAS office. round one, followed by a second round of amplification using the primer pair AS5͞AS6. These constructs were then used to transform the insertion-duplication mutant D39rr06 Ϫ . Putative mutants were checked by PCR using flanking oligonucleotides, and in-frame deletion was confirmed by sequence analysis. These mutants were designated D39⌬hk06 and D39⌬rr06, respectively.
Deletion mutations in hk06 and rr06 could not be constructed in TIGR4; however, mutants in which most of the gene was deleted and replaced with an erythromycin resistance cassette were created by using the method described in ref. 5 . Oligonucleotide combinations AS53͞AS5 and AS54͞AS6, along with AS60͞AS5 and AS61͞AS6, were used for production of flanking DNA of rr06 and hk06, respectively. The erythromycin cassette was amplified by using J214 and J215, and products were joined by using overlap-extension PCR and subsequently transformed into TIGR4. The mutants designated TIGR4hk06 and TIGR4rr06 were confirmed by PCR and sequencing.
SDS͞PAGE and Western Blotting. Bacteria were subjected to SDS͞ PAGE as described by Laemmli (20). Separated samples were then electroblotted onto nitrocellulose (Pall) as described (21) . After transfer, the membrane was probed with polyclonal murine antisera at a dilution of 1:3,000 and then reacted with blotting grade goat anti-mouse IgG alkaline phosphatase conjugate (BioRad). Labeled bands were visualized by using a nitroblue tetrazolium͞X-phosphate substrate system (Roche Diagnostics).
Expression and Purification of RR06. The RR06 ORF from S. pneumoniae D39 was amplified by using AS1 and AS2. The PCR product was digested with BamHI and HindIII, cloned into pQE30, and transformed into E. coli M15 (Qiagen) to generate a His-6 fusion. His-6-RR06 expression was induced by the addition of 2 mM IPTG. The recombinant protein was purified by nickel-nitrilotriacetic acid (Ni-NTA) affinity chromatography (Qiagen).
Immunization of Mice. His-6-RR06 antigen was formulated in aluminum hydroxide adjuvant (Alum) to a final ratio of 100 g of antigen to 1 mg of Alum adjuvant. CD-1 mice were then immunized i.p. with three doses of 10 g at 14-day intervals. Polyclonal mouse serum was collected by cardiac puncture 7 days after the final immunization and stored at 4°C until use. Mouse antisera against choline binding protein A (CbpA), PspA, Ply, and PsaA were prepared previously in the laboratory by using methods similar to those described for RR06.
RNA Extraction. RNA was extracted from S. pneumoniae strains by using the RiboPure bacteria kit (Ambion, Austin, TX) according to the manufacturer's instructions. RNA was resuspended in nuclease-free water in the presence of RNasin RNase inhibitor (Promega). Contaminating DNA was digested with DNase I (Roche Diagnostics), and the purity of all RNA isolations was confirmed by subjecting them to one-step RT-PCR analysis with or without reverse transcriptase by using 16s rRNA-specific primers (see Table 2 ).
Real-Time RT-PCR. Real-time RT-PCR was performed on a Rotorgene RG-2000 (Corbett Research, Mortlake NSW, Australia) by using the Access RT-PCR system (Promega) according to the manufacturer's instructions and essentially as described (22) .
Electrophoretic Mobility-Shift Assays. We labeled 10 pmol of PCRamplified promoter DNA by using digoxigenin (DIG)-11-dideoxy-UTP and terminal transferase according to the manufacturer's instructions (Roche Diagnostics). Cell extracts were prepared by lysing overnight cultures of E. coli K-12 expressing the appropriate protein by using a French pressure cell (Aminco-SLM, Urbana, IL). The protein concentrations in the cell extracts were determined by using a Bio-Rad protein-assay kit. Lysates containing specified protein concentrations were preincubated on ice with 100 g of herring sperm DNA in TM-1 buffer (25 mM Tris⅐HCl, pH 7.6͞100 mM KCl͞0.5 mM DTT͞5 mM MgCl 2 ͞0.5 mM EDTA͞10% glycerol) for 20 min. We then incubated Ϸ1 pmol of labeled DNA target with the mixture on ice for an additional 20 min. Binding reactions were loaded onto a preelectrophoresed 4% nondenaturing PAGE containing 1ϫ TBE and electrophoresed at 100 V for Ϸ2-3 h at 4°C. The DNA-protein complexes were then transferred onto Hybond-N ϩ membrane (Amersham Pharmacia) at 400 mA for 30 min by using 1ϫ TBE, and the DNA was then cross-linked and reacted with goat anti-DIG alkaline phosphatase conjugate (Roche Diagnostics). Labeled bands were visualized by using nitroblue tetrazolium͞X-phosphate substrate.
Solid-Phase Binding (SPB) Assay. The specific binding of RR06 to the cbpA promoter region was also investigated by using an SPB assay essentially as described (23) . We biotin end-labeled Ϸ40 pmol of DNA by using biotin-dideoxy-UTP and terminal transferase, according to the manufacturer's instructions (Roche Diagnostics). Strepdavidin MagneSphere Paramagnetic Particles (Promega) were washed three times in 1ϫ CB buffer (1 M NaCl͞5 mM Tris, pH 8.0͞0.5 mM EDTA). Labeled DNA was then bound to the beads in 1ϫ CB buffer with gentle agitation for 60 min at room temperature, followed by three washes in 1ϫ CB and three washes in TM-1. The protein-DNA binding reaction was performed in a total volume of 100 l, containing 50 g of specified lysate, 100 g of herring sperm DNA, and 0.6 mg of coated beads for 20 min on ice. After washing three times vigorously in binding buffer, bound proteins were eluted by boiling the beads for 5 min in lysis buffer and then analyzed by SDS͞PAGE and Western blotting using anti-RR06.
Adherence Assay. Adherence of pneumococci to A549 cells (human type II pneumocytes) and Detroit 562 cells (human nasopharyngeal cells) was determined as described (24) .
Intranasal Colonization Model. The ability of pneumococci to colonize the nasopharynx and translocate to the lungs and blood was investigated as described (25) .
Results

Effect of hk06 and rr06 Deletion on Pneumococcal Virulence Protein
Expression. We have demonstrated that several well characterized virulence genes of S. pneumoniae, including ply, pspA, psaA, and cbpA are differentially expressed under different environmental conditions (2) . Of these genes, cbpA (also known as pspC) was of particular interest, because it is located only 750 nt downstream of rr06͞hk06, and a number of prokaryotic TCSTSs regulate adjacent genes on the chromosome, including the blpH͞R system from the pneumococcus (26) . CbpA is an important pneumococcal virulence factor associated with nasopharyngeal colonization, adherence of pneumococci to epithelial cells, and the ability of the pathogen to cause lung infection (27, 28) . It binds the secretory component of sIgA, and also inhibits complement activation by binding C3 and factor H (29) (30) (31) . CbpA is also a protective immunogen in mice and has been proposed as a component of protein-based pneumococcal vaccines for use in humans (32) .
Accordingly, we used Western immunoblot analysis with polyclonal murine antisera to compare the levels of CbpA, as well as those of Ply, PspA, and PsaA, in lysates of D39, D39⌬hk06, and D39⌬rr06. Because a number of proteins are reported to be differentially expressed in opaque and transparent phase pneumococci (28) , all strains were confirmed to be in the transparent phase before Western immunoblot analysis.
Strains were grown to identical culture densities (A 600 ϭ 0.35 and 0.09 in THY and SB, respectively); equal numbers of cells were harvested, resuspended in lysis buffer, and then subjected to SDS͞PAGE and Western blotting. No differences were observed in the levels of Ply, PspA, and PsaA in D39, D39⌬hk06, and D39⌬rr06 lysates (data not shown). However, as shown in Fig. 1 , CbpA expression in both THY and SB appeared to be up-regulated in D39⌬hk06 and down-regulated in D39⌬rr06 compared with the parent strain. The culture supernatants from each strain were also tested for the presence of CbpA, and showed a similar result (data not shown), indicating that the differences seen in CbpA expression are not due to effects on anchorage of CbpA to the cell surface. The same changes in CbpA expression were also detected when the strains were in the opaque phase (data not shown).
Effect of ⌬hk06 and ⌬rr06 Mutations on Transcription of cbpA. To determine whether cbpA is transcriptionally coupled with hk͞ rr06, RT-PCR was performed by using D39 RNA template and primers from within the cbpA and hk06 genes (RTHis-Rev and RtcbpA-For; Table 2 ). No product was obtained (data not shown) indicating that cbpA and hk06 are transcribed separately. We then used real time RT-PCR with cbpA-specific primers (CbpAFNew and CbpAREdit; Table 2 ) to determine the relative levels of cbpA mRNA in cultures of D39, D39⌬hk06, and D39⌬rr06 grown in THY to an A 600 of 0.35. The 16S rRNA levels (determined in parallel using primers 16sF and 16sR) were used as an internal control. Real time RT-PCR was performed in quadruplicate on three independently isolated mRNA samples for each strain. In D39⌬hk06, the cbpA mRNA level was up-regulated Ϸ5-fold relative to that in D39 (P Ͻ 0.01), whereas in D39⌬rr06, cbpA mRNA was down-regulated 3-fold compared with the wild-type parent (P Ͻ 0.01) (Fig. 2) . This result correlates with the Western immunoblot analysis data, and it indicates that the regulation occurs at the level of transcription.
Real time RT-PCR was also used to study possible autoregulatory effects by examining the levels of rr06 and hk06 mRNA in D39⌬hk06 and D39⌬rr06, respectively, in comparison with the wild type, by using gene-specific oligonucleotides (RRf͞RRr and HKf͞HKr). No significant differences in level of rr06 and hk06 gene expression were observed (data not shown).
Binding of RR06 to the cbpA Promoter Region. The finding that deletion of either hk06 or rr06 results in altered transcription of cbpA compared with the wild type, suggests that transcription of cbpA might be directly regulated by binding of RR06 to DNA in the vicinity of the cbpA promoter. A 377-bp DNA region corresponding to nucleotides Ϫ299 to 78 relative to the cbpA initiation codon (nucleotides 1,989,574-1,989,939 of the S. pneumoniae R6 genome; GenBank accession no. AE007317) was PCR-amplified and labeled with DIG-11-dideoxy-UTP, as described in Materials and Methods. To overexpress RR06, the rr06 gene was cloned into pGEM-T Easy and transformed into E. coli DH5␣. As a control, the rr13 gene, which encodes another pneumococcal RR, was also cloned into pGEM-T Easy and transformed into DH5␣. Cell lysates of DH5␣, carrying either pGEM-T Easy (DH5␣:pGEMT), or its derivatives, containing rr06 (DH5␣:RR06) and rr13 (DH5␣:RR13), were prepared. Aliquots of each lysate containing 10 g of protein were incubated with the labeled cbpA promoter fragment. Reaction mixtures were then electrophoresed, transferred to a nylon filter, and developed. Incubation of the DH5␣:RR06 lysate with the labeled cbpA promoter DNA caused a marked decrease in the electrophoretic mobility of the DNA fragment, which was not seen with the control lysate (DH5␣:pGEMT) or the lysate from DH5␣:RR13 (Fig. 3) . The mobility shift could be completely inhibited by coincubation of the DIG-labeled DNA fragment with DH5␣:RR06 and a 100-fold excess of unlabeled cbpA promoter DNA (Fig. 3) . These results suggest that this shift is specific for RR06, providing strong evidence for the binding of RR06 to the cbpA promoter region.
To investigate the specificity of RR06-cbpA promoter interaction further, a SPB assay was undertaken. The cbpA promoter region, or an internal fragment of the 16S rRNA gene, was biotin labeled and attached to Strepdavidin MagneSphere Paramagnetic Particles. The beads were subsequently incubated with cell lysates of DH5␣:pGEMT or DH5␣:RR06. After washing in the presence of herring sperm competitor DNA, bound protein was eluted by boiling the beads in lysis buffer. These samples along with crude E. coli lysates were then probed for presence of RR06 by Western blot using anti-RR06 serum. The antiserum reacted strongly with a 25-kDa (the expected size of RR06) species in the DH5␣:RR06 crude lysate, but it did not label any protein species in the crude lysate of DH5␣:pGEMT (data not shown). The antiserum labeled a 25-kDa species in the eluate from the cbpA promoter-coated beads that had been incubated with the DH5␣:RR06 lysate, but no such species was labeled in the eluate of beads incubated with DH5␣:pGEMT (Fig. 4) . As a further control, an internal fragment of the 16S rRNA gene was coated onto the beads and incubated with either lysate, but no RR06 binding was detected (Fig. 4) . These data confirm the specificity of binding of RR06 to the cbpA promoter region.
Adherence to A549 and Detroit 562 Cells. Ref. 28 demonstrated that a mutant deficient in CbpA production has reduced adherence to A549 cells (type II pneumocytes). Given the apparent role of RR06͞HK06 in regulation of cbpA expression, the in vitro adherence of D39, D39⌬hk06, and D39⌬rr06 to human lung (A549) and nasopharyngeal (Detroit 562) cell lines was investigated. For comparative purposes, a D39 cbpA Ϫ insertionduplication mutant that was previously constructed in this laboratory was tested also (33) .
We incubated Ϸ2 ϫ 10 6 pneumococci with confluent cell monolayers in 24-well plates, and the number of adherent bacteria was determined as described in Materials and Methods. Total adherence of wild-type D39 to the A549 cells was Ϸ4.4 ϫ 10 4 colony-forming units (CFU) per well, but that of either D39⌬hk06 or D39⌬rr06 was Ϸ75% lower (P Ͻ 0.001; Fig. 5A ). The D39 CbpA Ϫ mutant exhibited an additional significant decrease in adherence compared with the TCSTS mutants (D39⌬hk06 vs. CbpA Ϫ , P Ͻ 0.001; D39⌬rr06 vs. CbpA Ϫ , P Ͻ 0.05). Adherence of D39 to Detroit 562 cells was Ϸ3.1 ϫ 10 4 CFU per well, and again, both the D39⌬hk06 and D39⌬rr06 mutants showed a statistically significant reduction in adherence (P Ͻ 0.001). D39⌬rr06 also exhibited significantly lower adherence than D39⌬hk06 (P Ͻ 0.05). The adherence of the D39CbpA Ϫ mutant to Detroit 562 cells was Ϸ75% lower than that of D39 (P Ͻ 0.001) but was not significantly different from that of either D39⌬hk06 or D39⌬rr06 (Fig. 5B) . Also, Western immunoblot analysis was undertaken to investigate the level of CbpA expression during the adherence assay. In accordance with data presented above for bacteria grown in THY or SB, D39⌬hk06 exhibited up-regulation of CbpA relative to the wild type, whereas D39⌬rr06 exhibited down-regulation (data not shown).
In Vivo Studies. To investigate the role of RR06͞HK06 in nasopharyngeal colonization and virulence, groups of 18 CD-1 mice were inoculated intranasally with D39, D39⌬hk06, D39⌬rr06, or D39CbpA Ϫ at a dose of Ϸ2 ϫ 10 7 CFU. At least five mice from each group were killed after 24, 48, and 96 h, and the numbers of pneumococci in the nasopharynx, lungs, and blood were determined (Fig. 6) . The results presented are pooled from two independent experiments. Although neither D39⌬hk06 nor D39CbpA Ϫ appeared to show any significant difference in nasopharyngeal colonization compared with the parent strain, D39⌬rr06 showed a statistically significant increase in number of pneumococci colonizing the nasopharynx at both 48 and 96 h (P Ͻ 0.05 and P Ͻ 0.01, respectively; unpaired two-tailed Student's t test). Translocation to the lungs and blood at 96 h appeared to be severely affected in D39⌬hk06, with only 1 of 16 mice showing evidence of bacteria in the lungs or blood in the two experiments. In contrast, 13 and 9 of the 16 mice infected with D39 had pneumococci in the lungs and blood, respectively (P Ͻ 0.001 and P Ͻ 0.025; Fisher's exact test). However, at the same time point, D39⌬rr06 showed a significant increase in its ability to cause infection in the lung (P Ͻ 0.05). D39CbpA Ϫ showed no differences relative to the wild type in either its ability to colonize the nasopharynx or translocate to the lungs and blood.
Mutagenesis of rr06͞hk06 in Strain TIGR4. To examine whether the effects of RR06͞HK06 on cbpA expression were influenced by host strain, insertion mutations were constructed in rr06 and hk06 in the type 4 strain TIGR4 (see Materials and Methods). The TIGR4hk06 mutant exhibited increased cbpA expression relative to the wild-type parent, as judged by both Western immunoblotting and real time RT-PCR (using oligonucleotides AS62 and AS64 specifically designed for the TIGR4 cbpA gene). However, cbpA expression in TIGR4rr06 was similar to that of the parent strain (data not shown). 
Discussion
Coordinated regulation of virulence genes is likely to be fundamental to the capacity of S. pneumoniae to asymptomatically colonize the nasopharynx and cause invasive disease in humans. In this study, we investigated the role of the TCSTS RR06͞HK06 in regulation of the expression of CbpA, an important pneumococcal virulence factor. By using Western immunoblot analysis, we have demonstrated differential expression of cbpA in the TCSTS mutants D39⌬hk06 and D39⌬rr06 relative to the wildtype parent. RT-PCR was also used to exclude the possibility that cbpA and rr06͞hk06 are cotranscribed with cbpA. Moreover, real time RT-PCR analysis indicated that the regulation of cbpA occurred at the level of transcription and not through a posttranscriptional effect. These data suggested that, in D39, RR06͞ HK06 exerts regulatory control over cbpA.
Confirmation of the above findings in the unrelated TIGR4 strain was complicated by inability to construct unmarked inframe deletion mutants in this background. However, an insertion mutant, TIGR4hk06, also exhibited up-regulation of cbpA at both the protein and mRNA level compared with the wild type. However, differences in cbpA expression were not observed for TIGR4rr06. A difference in findings between the same two S. pneumoniae strains (D39 and TIGR4) has recently been reported with respect to the effects of mutations in a different TCSTS (TCS04) on expression of the Mn transporter PsaA (10) . Although the genes encoding hk06 and rr06 are highly conserved, as is the promoter region upstream of cbpA, TIGR4 and D39 vary substantially in genome sequence (34) and, hence, may differ in some other regulatory element affecting cbpA expression.
The up-regulation of cbpA detected in D39⌬hk06 suggests that RR06 can be activated independently of HK06, perhaps through small-molecular-weight phosphodonors such as acetyl phosphate or other noncognate HKs. Systems such as CheY, PhoB͞PhoR, and NtrB͞NtrC from E. coli are examples of systems that are able to be activated in this manner (35) (36) (37) . The higher level of CbpA is likely to occur because of HK06 possessing phosphatase as well as kinase activity, a trait commonly found among HK proteins. Thus, in noninducing conditions, a higher level of the regulated gene would be produced in the absence of HK phosphatase activity. More RR06 would be phosphorylated through other intermediaries, leading to an increased level of cbpA. This other phosphate intermediary remains to be identified, and it remains to be determined whether it is a noncognate HK or other phosphodonor.
In most prokaryotic TCSTSs, regulation occurs by means of the RR binding to the promoter region of the regulated gene. In this study, electrophoretic mobility shift and SPB assays provided strong evidence for the specific binding of RR06 to the promoter region of cbpA. The electrophoretic mobility-shift assay showed a marked, albeit incomplete, retardation in mobility, which was only observed when the target DNA fragment was incubated with lysates of E. coli K-12 expressing the RR06 protein. This shift in mobility could be competitively inhibited by excess unlabeled target DNA (Fig. 3) , indicating that the interaction was specific for the cbpA promoter region. SPB assays rely on the ability of target DNA coupled to a substrate to bind the RR (in this case, RR06). Our results indicate that a protein of Ϸ25 kDa in the DH5␣:RR06 lysate bound to immobilized cbpA DNA target and that this protein reacted with anti-RR06. We conclude that the cbpA promoter region acts as one possible binding site for RR06. However, BLAST searches have not identified regions with significant DNA homology elsewhere in the S. pneumoniae genome. This fact may not be surprising because OmpR, the founder member of the family to which RR06 belongs, binds to a basic consensus sequence that varies markedly (5, 38) .
The ability of the pneumococcus to adhere to host epithelial cells is particularly important to the pathogenesis of disease, especially in the nasopharynx where the pathogen can reside for extended periods without causing disease. Such asymptomatic colonization is a precursor to invasive disease, but carriers are also the principal reservoir for S. pneumoniae, which is a Fig. 6 . Numbers of D39, D39⌬hk06, D39⌬rr06, and D39CbpA Ϫ in the nasopharynx (Top), lungs (Middle), and blood (Bottom) after intranasal challenge. Mice were challenged with Ϸ2 ϫ 10 7 CFU and killed at 24, 48, and 96 h, and the numbers of bacteria in the various compartments were determined. Data are mean log 10 CFU Ϯ standard error. Significant difference from the wild type was determined ( ** , P Ͻ 0.01; * , P Ͻ 0.05; two-tailed unpaired Student's t test).
human-specific pathogen. Work by Rosenow and coworkers (28) has shown that CbpA mediates the adherence of pneumococci to A549 cells (human type II pneumocytes). In this study, both D39⌬hk06 and D39⌬rr06 showed a reduction in adherence to A549 as well as Detroit 562 (human nasopharyngeal) cells. The findings for D39⌬hk06 were unexpected, given the increase in cbpA expression in this mutant. Additional Western immunoblot analysis confirmed that the relative expression of CbpA was unaffected by either tissue culture medium or contact with the eukaryotic cells. These findings clearly implicate additional, as yet uncharacterized, RR06͞HK06-regulated factors in adherence to epithelial cells of human origin.
The results from the in vivo experiments are not easy to reconcile with the in vitro adherence data. This discrepancy is not surprising given the likelihood of differences in receptor expression between transformed human cell lines and mouse respiratory epithelium. Although CbpA is clearly important for in vitro adherence, mutation of cbpA had no obvious effect on either colonization of the murine nasopharynx or progression to pulmonary or systemic disease. In contrast, D39⌬rr06 exhibited increased colonization capacity, whereas D39⌬hk06 was deficient in its capacity to invade the lungs and blood relative to D39. These data clearly indicate that other uncharacterized RR06͞ HK06-regulated factors have a significant role in both colonization and invasive disease, at least in the mouse model. Identification of such factors may possibly yield important new targets for vaccines and novel drugs, capable of interfering with the capacity of S. pneumoniae to establish infection and progress to invasive disease in humans.
